Dr. Osman Köse

Dr. Osman Köse's medical career began with his graduation from Gülhane Military Medical Academy, Faculty of Military Medicine in 1986. He completed his specialization in dermatology at GATA Skin and Venereal Diseases Department, Ankara, between 1990 and 1993. His tenure at Çorlu Military Hospital's Dermatology and Venereology service spanned six years.

In 1999, Dr. Köse embarked on his academic journey as an Assistant Professor, achieving the rank of Associate Professor in 2002. He furthered his expertise with a year-long research stint at the University of London's Royal London Hospital in 2003-2004, focusing on epidermal cell cultures and Behçet's Disease, supported by a TÜBİTAK Postdoctoral Study Abroad Scholarship. His academic accomplishments led to his professorship in 2008.

Dr. Köse has a prolific publication record with 62 international and 52 domestic scientific studies. His expertise has been sought after in numerous conferences globally, with 20 presentations as an invited speaker and 40 national speeches. He has been a contributing member of the European Pediatric Dermatology Board (ESPD) since 2008 and served on the Turkish Dermatology Association (TDD) board from 2012 to 2018.

His clinical interests are diverse, with a particular focus on Cosmetic Dermatology, Pediatric Dermatology, Sexually Transmitted Diseases, Skin Stem Cells, and Behçet's Disease. He has contributed to the medical community with numerous presentations at major international dermatology conferences and has authored a book on Pediatric Dermatology.

• M.D.: Gülhane Military Medical Academy Faculty of Medicine, 1986.
• Residency: Dermatology, Gülhane Military Medical Academy Faculty of Medicine, Ankara, Turkey, 1990-1993.

• Professor, Private Office, Sep 2019 - Currently · 4 years 4 months, Ankara, Turkey.
• Professor, Gülhane School of Medicine, Department of Dermatology, 1993-2012, Ankara, Turkey.

• Member of the European Pediatric Dermatology Board of Directors –ESPD- (Board Member) since 2008.
• Member of the Board of Directors of the Turkish Dermatology Association (TDD) between 2012-2018.

• 8th. Zagazig International Conference of Dermatology and Venereology; April 15-20, 1994; Cairo, Egypt.

1. Balkan Military Medicine Congress; May 10-15, 1998; Athens, Greece.

• Mediterranean Countries Dermatology Congress (AMED, Congress of the Mediterranean Association of Dermatology); May 23-27, 2001; Antalya, Turkey.
• 7th Congress of European Society for Paediatric Dermatology; November 21-23, 2002; Barcelona, Spain.
• 11th International Conference on Behcet's disease; October 27-31, 2004; Antalya, Turkey.
• 12th International Conference on Behcet's disease; October 20-23, 2006; Lisbon, Portugal.
• 9th Congress of European Society for Paediatric Dermatology; May 15-17, 2008; Athens, Greece.
• 11th World Congress of Pediatric Dermatology; November 17-19, 2009; Bangkok, Thailand.
• 1st Turkish Regional HPV Meeting; November 25-28, 2010; Cesme – Izmir, Turkey.
• 22nd World Congress of Dermatology; May 3-7, 2011; Seoul, Korea.
• 20th EADV congress; October 20-24, 2011; Lisbon, Portugal.
• 11th European Pediatric Dermatology Congress; May 19-23, 2012; Istanbul.
• 12th World Congress of Pediatric Dermatology; September 25-27, 2013; Madrid, Spain.
• 22nd EADV Congress; October 2-6, 2013; Istanbul, Turkey.
• 12th European Congress of Pediatric Dermatology; June 5-7, 2014; Kiel, Germany.
• 7th Vitiligo Meetings; November 24, 2014; Istanbul, Turkey.
• 8th Vitiligo Meetings; May 22-24, 2015; Sofia, Bulgaria.
• 23rd World Congress of Dermatology; June 5-9, 2015; Vancouver, Canada.
• 16th Iran National Dermatology Congress; January 3-6, 2017; Tehran, Iran.
• 13th World Congress on Pediatric Dermatology; July 6-9, 2017; Chicago, USA.
• 18th European Congress of Pediatric Dermatology; July 3-6, 2018; London, England.

• Treatment with intralesional interferon alpha-2a of genital warts with human papillomavirus genotyping, 8th. Zagazig International Conference of Dermatology and Venereology, 15-20 April 1994, Cairo, Egypt.
• Clinical comparative study of terbinafine and itraconazole in the treatment of tinea pedis, tines cruris and tinea corporis, 3. Balkan Military Medicine Congress, May 10-15, 1998, Athens, Greece.

• Köse O, Aras N, Sutman K, Gur AR. Treatment with intralesional interferon alpha-2a of genital warts with human papillomavirus genotyping. J Dermatol Treat 1994:5:223-224.
• Aras N, Sutman K, Köse O, Gur AR, Askin C. Clinical comparative study of terbinafine and itraconazole in the treatment of tinea pedis, tines cruris and tinea corporis. Afr J Dermatol 1994:7(1):23-27.
• Köse O. Fluconazole versus itraconazole in the treatment of tinea versicolor. Int J Dermatol 1995:34:7;498-499.
• Köse O. Baloglu H. Knuckle pads, leukonychia and deafness. Int J Dermatol 1996: 35; 728-729.
• Köse O. Baloglu H. Idiopathic unilateral circumscribed hyperhidrosis. Int J Dermatol 1997:36:209-210.
• Köse O. Calcipotriol ointment vs clobetasol solution in scalp psoriasis. J Dermatol Treat 1997;8:287-8.
• Köse O, Taştan HB, Deveci S, Gür AR. Anhidrotic Ectodermal Dysplasia with Eruptive Vellus Hair Cysts. Int J Dermatol 2001: 40: 6; 401-402.
• Köse O, Akar A, Safalı M, Taştan HB, Kurumlu Z, Gür AR. Focal epithelial hyperplasia treated with interferon alpha–2a. J Dermatol. Treat. 2001:12;2: 111-113.
• Sayar K, Köse O, Ebrinç S, Çetin M. Hopelessness, depression, and alexithymia in young Turkish soldiers suffering from Alopecia areata. Dermatol Psychosom 2001;2:12-15.
• Köse O, Sayar K, Ebrinç S. Psychometric assessment of Alopecia Areata patients before and after dermatological treatment. Clinical Psychopharmacology Bulletin 2000;10(1):21.
• Köse O, Gür AR, Kurumlu Z, Erol E. Calcipotriol ointment versus Clobetasol ointment in localized vitiligo (Open-comparative clinical trial). Int J Dermatol 2002; 41;616-618.
• Köse O, Taştan HB, Gür AR, Kurumlu Z. Comparison of single dose 400 mg versus 7-day 200 mg daily dose Itraconazole in the treatment of tinea versicolor. J Dermatol. Treat. 2002:13;2;77-80.
• Köse O, Arca E, Taştan HB, Gür AR. Acitretin in recalcitrant and extensive plantar warts. Retinoids 2003;19:13-14.
• Arca E, Tüzün A, Tastan HB, Akar A, Köse O. Dyskeratosis Congenita with eosophagial and anal structure. Int J Dermatol 2003; 42(7);555-557.
• Köse O, Safalı M, Tastan HB, Gür AR. Mycophenolate mofetil in extensive Alopecia areata: no effect in seven patients. Dermatology 2004;209(1):69-70.
• Arca E, Köse O, Tastan HB, Gür AR. Follicular mucinosis responding to isotretinoin treatment. J Dermatolog Treat 2004;15(6):391-395.
• Arca E, Açıkgöz G, Tastan HB, Köse O. Kurumlu Z. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology 2004;209(2):117-125.
• Köse O, Erbil H, Gür AR. Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial. J Eur Acad Dermatol Venereol. 2005; 19(2):172-175.
• Köse O, Safalı M, Gür AR. Atrophoderma vermiculatum with Melkersson-Rosenthal syndrome. Dermatology 2005;210(1):76-77.
• Arca E, Köse O, Erbil AH, Nişancı M, Akar A, Gür AR. A case of 2-year-old girl with Stevens-Johnson/toxic epidermal necrolysis treated with intravenous immunoglobulin. Pediatr Dermatol 2005;22(4):317-320.
• Köse O, Arca E, Akgül Ö, Erbil K. The levels of serum neopterin in Behçet's disease-objective marker of disease activity. J Dermatol Sci 2006;42:128-130.
• Arca E, Köse O, Karslıoğlu Y, Taştan HB, Demiriz M. Bullous eosinophilic cellulitis succession with eosinophilic pustular folliculitis without eosinophilia. J Dermatol 2007;34:80-85.
• Akgul B, Köse O, Safali M, Purdie K, Cerio R, Proby C, Storey A. A distinct variant of Epidermodysplaisa verruciformis in a Turkish family EVER1 and EVER2 mutations. J Dermatol Sci 2006;44:144-146.
• Arca E, Tastan HB, Köse O. Giant Kaposi’s varicelliform eruption in Darier’s disease. J Dermatolog Treat 2007;18:110-112.
• Köse O, Erbil H, Özer A. Early changes in cutaneous microcirculation in response to different vasoactive agents in psoriasis. J Dermatol 2008;35:96-102.
• Köse O, Arca E, Tastan HB, Gür AR, Kurumlu Z. Dapsone in pityriasis lichenoides. J Dermatolog Treat 2009;20(5):306-308.
• Arca E, Erbil H, Köse O. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as diagnostic criteria of Behçet's disease? Skin Appendage Disord 2017;3:109-112.